Common Contracts
9 similar Underwriting Agreement contracts by Affymax Inc, American Superconductor Corp /De/, Biocryst Pharmaceuticals Inc, others
4,600,000 Shares AMERICAN SUPERCONDUCTOR CORPORATION COMMON STOCK ($.01 par value) UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2010 • American Superconductor Corp /De/ • Motors & generators • New York
American Superconductor Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you are acting as managers (the “Managers”), the number of shares of its common stock, $.01 par value per share, set forth in Schedule I hereto (the “Firm Shares”).
●] Shares ShengdaTech, Inc. Common Stock, $0.00001 Par Value Per Share UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2010 • ShengdaTech, Inc. • Miscellaneous chemical products • New York
The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with ShengdaTech, Inc., a Nevada corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including you (the “Underwriters”), of [●] shares (the “Shares”) of the common stock, $0.00001 par value per share of the Company (the “Common Stock”).
OCLARO, INC. COMMON STOCK, $0.01 PAR VALUE UNDERWRITING AGREEMENTUnderwriting Agreement • May 7th, 2010 • Oclaro, Inc. • Semiconductors & related devices • New York
Shares CONSECO, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • December 14th, 2009 • Conseco Inc • Accident & health insurance • New York
Morgan Stanley & Co. Incorporated As Representative of the Several Underwriters listed in Schedule I hereto c/o Morgan Stanley & Co. Incorporated 1585 Broadway New York, New York 10036
5,000,000 Shares BIOCRYST PHARMACEUTICALS, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 24th, 2009 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Biocryst Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for which you are acting as representative (the “Representative”), the number of shares of its Common Stock, par value $0.01 per share set forth in Schedule I hereto (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than the number of additional shares of its Common Stock, par value $0.01 per share set forth in Schedule I hereto (the “Additional Shares”) if and to the extent that the Representative shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of Common Stock, par value $0.01 per share of the Company to be outstanding after giving effe
CENTRAL VERMONT PUBLIC SERVICE CORPORATION COMMON STOCK, PAR VALUE $6.00 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 19th, 2008 • Central Vermont Public Service Corp • Electric services • New York
The undersigned understands that Morgan Stanley & Co. Incorporated (“Morgan Stanley”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Central Vermont Public Service Corporation, a Vermont corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including Morgan Stanley (the “Underwriters”), of ___ shares (the “Shares”) of the common stock, par value $6.00 per share, of the Company (the “Common Stock”).
CITIZENS REPUBLIC BANCORP, INC. COMMON STOCK, NO PAR VALUE UNDERWRITING AGREEMENTUnderwriting Agreement • June 11th, 2008 • Citizens Republic Bancorp, Inc. • National commercial banks • New York
6,250,000 Shares CAVIUM NETWORKS, INC. COMMON STOCK (PAR VALUE $0.001) UNDERWRITING AGREEMENTUnderwriting Agreement • April 30th, 2007 • Cavium Networks, Inc. • Semiconductors & related devices • New York
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock, (2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise or (3) publicly announce the intent to do any of the foregoing. Any Shares received upon exercise of options or other convertible securities granted to the undersigned will also be subject to this agreement. The first sentence in this paragraph shall not apply to transactions relating to (a) the exercise of any options to acquire Common Stock or conversion of any convertible s
• Shares AFFYMAX, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 30th, 2006 • Affymax Inc • Pharmaceutical preparations • New York
Morgan Stanley & Co. Incorporated Cowen and Company, LLC Thomas Weisel Partners LLC RBC Capital Markets c/o Morgan Stanley & Co. Incorporated 1585 Broadway New York, NY 10036
